Cargando…

Inhibition of SGLT2 Preserves Function and Promotes Proliferation of Human Islets Cells In Vivo in Diabetic Mice

Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor used for the treatment of diabetes. This study examines the effects of dapagliflozin on human islets, focusing on alpha and beta cell composition in relation to function in vivo, following treatment of xeno-transplanted diabetic mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karlsson, Daniel, Ahnmark, Andrea, Sabirsh, Alan, Andréasson, Anne-Christine, Gennemark, Peter, Sandinge, Ann-Sofie, Chen, Lihua, Tyrberg, Björn, Lindén, Daniel, Sörhede Winzell, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868601/ https://www.ncbi.nlm.nih.gov/pubmed/35203411 http://dx.doi.org/10.3390/biomedicines10020203

Ejemplares similares

Inhibition of the prostaglandin D(2)–GPR44/DP2 axis improves human islet survival and function
por: Abadpour, Shadab, et al.
Publicado: (2020)

Disturbed α-Cell Function in Mice with β-Cell Specific Overexpression of Human Islet Amyloid Polypeptide
por: Ahrén, Bo, et al.
Publicado: (2008)

The SGLT2 inhibitor dapagliflozin promotes systemic FFA mobilization, enhances hepatic β-oxidation, and induces ketosis
por: Wallenius, Kristina, et al.
Publicado: (2022)

Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction
por: Hansson, Sara F., et al.
Publicado: (2018)

Input estimation for drug discovery using optimal control and Markov chain Monte Carlo approaches
por: Trägårdh, Magnus, et al.
Publicado: (2016)

The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1
por: Sundström, Linda, et al.
Publicado: (2017)

GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans
por: Stone, Virginia M., et al.
Publicado: (2014)

The Effects of Exendin-4 Treatment on Graft Failure: An Animal Study Using a Novel Re-Vascularized Minimal Human Islet Transplant Model
por: Sahraoui, Afaf, et al.
Publicado: (2015)

Long noncoding RNAs are dynamically regulated during β-cell mass expansion in mouse pregnancy and control β-cell proliferation in vitro
por: Sisino, Giorgia, et al.
Publicado: (2017)

A method for the generation of human stem cell-derived alpha cells
por: Peterson, Quinn P., et al.
Publicado: (2020)

The Connexin 43 Regulator Rotigaptide Reduces Cytokine-Induced Cell Death in Human Islets
por: Ghiasi, Seyed Mojtaba, et al.
Publicado: (2020)

Exploring the insulin secretory properties of the PGD(2)-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients
por: Skrtic, Stanko, et al.
Publicado: (2018)

Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes
por: Segerstolpe, Åsa, et al.
Publicado: (2016)

Unraveling the pharmacokinetic interaction of ticagrelor and MEDI2452 (Ticagrelor antidote) by mathematical modeling
por: Almquist, J, et al.
Publicado: (2016)

Quantification of unbound concentration of ticagrelor in plasma as a proof of mechanism biomarker of the reversal agent, MEDI2452
por: Sandinge, Ann-Sofie, et al.
Publicado: (2018)

A Variation on the Theme: SGLT2 Inhibition and Glucagon Secretion in Human Islets
por: Hodson, David J., et al.
Publicado: (2020)

Islet expression of the DNA repair enzyme 8-oxoguanosine DNA glycosylase (Ogg1) in human type 2 diabetes
por: Tyrberg, Björn, et al.
Publicado: (2002)

PPARγ and PPARα synergize to induce robust browning of white fat in vivo
por: Kroon, Tobias, et al.
Publicado: (2020)

EMPEROR-Preserved: SGLT2 inhibitors breakthrough in the management of heart failure with preserved ejection fraction
por: Wagdy, Kerolos, et al.
Publicado: (2021)

Retrospective analysis of SGLT2 inhibitors in heart failure with preserved ejection fraction
por: Clemmer, John S., et al.
Publicado: (2023)

Pancreas Procurement and Preservation for Islet Transplantation: Personal Considerations
por: Noguchi, Hirofumi
Publicado: (2011)

Assessment of Culture/Preservation Conditions of Human Islets for Transplantation
por: Shindo, Yoshitaro, et al.
Publicado: (2022)

364 Beneficial Actions of SGLT2 Inhibition and H2S Therapy in Heart Failure with Preserved Ejection Fraction
por: Doiron, Jake, et al.
Publicado: (2023)

The development of a GPR44 targeting radioligand [(11)C]AZ12204657 for in vivo assessment of beta cell mass
por: Jahan, Mahabuba, et al.
Publicado: (2018)

Islet-1 is Required for the Maturation, Proliferation, and Survival of the Endocrine Pancreas
por: Du, Aiping, et al.
Publicado: (2009)

Altered pancreatic islet morphology and function in SGLT1 knockout mice on a glucose-deficient, fat-enriched diet
por: Mühlemann, Markus, et al.
Publicado: (2018)

SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function
por: Jurczak, Michael J., et al.
Publicado: (2011)

Emerging Horizons in Heart Failure with Preserved Ejection Fraction: The Role of SGLT2 Inhibitors
por: Heath, Rebecca, et al.
Publicado: (2022)

Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Pabel, Steffen, et al.
Publicado: (2021)

Culture on a native bone marrow-derived extracellular matrix restores the pancreatic islet basement membrane, preserves islet function, and attenuates islet immunogenicity
por: Wang, Hanzhou, et al.
Publicado: (2020)

SGLT2i: beyond the glucose-lowering effect
por: Ni, Lihua, et al.
Publicado: (2020)

Homeostatic T Cell Proliferation after Islet Transplantation
por: Monti, Paolo, et al.
Publicado: (2013)

Are SGLT-2 Inhibitors the Future of Heart Failure Treatment? The EMPEROR-Preserved and EMPEROR-Reduced Trials
por: Williams, David M., et al.
Publicado: (2020)

Hyperglycemia Induced by Glucokinase Deficiency Accelerates Atherosclerosis Development and Impairs Lesion Regression in Combined Heterozygous Glucokinase and the Apolipoprotein E-Knockout Mice
por: Adingupu, Damilola D., et al.
Publicado: (2016)

MafA Expression Preserves Immune Homeostasis in Human and Mouse Islets
por: Singh, Tania, et al.
Publicado: (2018)

Subcutaneous delivery of FGF21 mRNA therapy reverses obesity, insulin resistance, and hepatic steatosis in diet-induced obese mice
por: Bartesaghi, Stefano, et al.
Publicado: (2022)

SGLT2 Inhibitors and Their Antiarrhythmic Properties
por: Kolesnik, Ewald, et al.
Publicado: (2022)

Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF
por: Bode, David, et al.
Publicado: (2021)

Integrated experimental-computational analysis of a HepaRG liver-islet microphysiological system for human-centric diabetes research
por: Casas, Belén, et al.
Publicado: (2022)

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
por: Nassif, Michael E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rikr5foqkkov3sccgg698j5oq9